Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Firms In Hot Chase To Market Generic Sovaldi

This article was originally published in PharmAsia News

Executive Summary

In a span of less than two weeks, at least five Indian drug makers have announced the introduction of their cut price versions of generic Sovaldi in the market. As the race is set to intensify further in the coming months, experts believe the most notable gains will accrue to those who get their pricing right, have a wide marketing footprint and devise market-building strategies to connect with untreated patients.



Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts